ANDREI HETMAN
Allopathic & Osteopathic Physicians|Internal Medicine BROOKSVILLE, FL NPI 1003203142
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine FL Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$1,004.59
- Category: General Payments
- Program years: PY2018–2021
- Record count: 46
- As of (CMS publication): 2026-01-23
Latest program year (PY2021): $148.67 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2021) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $148.67 | 7 |
By paying entity
Latest program year (PY2021) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $70.62 | 3 |
| GlaxoSmithKline, LLC. | $40.66 | 2 |
| Acerta Pharma LLC | $23.39 | 1 |
| Actelion Pharmaceuticals US, Inc. | $14.00 | 1 |
By program year
Records — PY2021 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 763308194 | Boehringer Ingelheim Pharmaceuticals, Inc. | $22.75 | 05/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 763308196 | Boehringer Ingelheim Pharmaceuticals, Inc. | $20.70 | 03/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 763308198 | Boehringer Ingelheim Pharmaceuticals, Inc. | $27.17 | 02/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 788921969 | Actelion Pharmaceuticals US, Inc. | $14.00 | 04/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 801951629 | GlaxoSmithKline, LLC. | $27.29 | 06/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 803154469 | GlaxoSmithKline, LLC. | $13.37 | 03/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 830122147 | AstraZeneca Pharmaceuticals LP | $23.39 | 05/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.